Retraction notices

Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications

Type

Retraction

Notice date

6/15/2012 0:00

Journal

The Journal of Pharmacology and Experimental Therapeutics

Publisher

ASPET: American Society for Pharmacology and Experimental Therapeutics

Notice DOI

Not recorded

Original paper DOI

10.1124/jpet.111.190918

Reasons

• Breach of Policy by Author
• Concerns/Issues about Data
• Lack of Approval from Company/Institution